Estimate Recalculated Nov 8, 2024 09:32PM EST
Sue Gail Eckhardt does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Syros Pharmaceuticals, Inc., and EXELIXIS, INC..
Sue Gail Eckhardt's CIK is 0001823769
2024 was Sue Gail Eckhardt's most active year for acquiring shares with 5 total transactions. Sue Gail Eckhardt's most active month to acquire stocks was the month of May. 2020 saw Sue Gail Eckhardt paying a total of $0.00 for 35,000 shares, this is the most they've acquired in one year.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!